Corvus Pharmaceuticals CRVS Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's interest income?
- Corvus Pharmaceuticals (CRVS) reported interest income of $1.78M in Q1 2026.
- How has Corvus Pharmaceuticals's interest income changed year-over-year?
- Corvus Pharmaceuticals's interest income increased by 239.8% year-over-year, from $525K to $1.78M.
- What is the long-term trend for Corvus Pharmaceuticals's interest income?
- Over 3 years (2022 to 2025), Corvus Pharmaceuticals's interest income has grown at a 56.5% compound annual growth rate (CAGR), from $654K to $2.51M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.